Visual outcomes following anti-VEGF therapy in patients with DME
Indian Journal of Ophthalmology · 2024
DOI: 10.4103/ijo.ijo_40_24 ↗Kurz gefasst
Leserbrief in der Zeitschrift Indian Journal of Ophthalmology, 2024. Verfasst von Pradeep K Panigrahi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be) University, 8-Kalinga Nagar, Bhuban…. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Visual Acuity, Intravitreal Injections. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Dear Editor, We went through the article titled “Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema” by Rana et al.[1] We would like to congratulate the authors for their research work. We have a few queries for the authors. In the Methods section, it has been clearly mentioned that patients with uncontrolled hypertension were excluded from the study. However, in the Results section, it has been mentioned that only 12 patients had hypertension under control. It will be informative to know the hypertension status of the remaining five patients enrolled in the study. If the blood pressure of these patients was fluctuating or not under control, then they should ideally have not been enrolled in the study. Similarly, it has been pointed out that patients with renal failure requiring dialysis or renal transplant were excluded from the study. Now patients with nephropathy not requiring either of the above can suffer from anemia which can affect the macular edema and response to treatment. They additionally suffer from hypertension. So all patients with nephropathy with anemia should have ideally been excluded from the study. Hyper-reflectivity of the intraretinal cysts has been considered to be one factor associated with poor post-treatment response. Three patients in the responder group and all patients in the non-responder group had increased reflectivity of the cysts. It will be good to know if the amount of hyper-reflectivity was similar in patients of both groups. Also, if hyper-reflectivity is to be considered as a criterion, then was there any change in the reflectivity of the cysts following injection in patients in the responder group? The size of the intra-retinal cysts has also been mentioned as a predictive factor with patients in the non-responder group having larger cysts size at baseline as compared to the responder group. Now a closer look at the table provided shows that only one patient in the responder group with cyst size between 400 and 600 microns at baseline has moved to the sub 400 microns group 3 months following injection. If an anatomical factor like cyst size is to be considered as a predictor, then the majority of the patients in the responder group should have undergone cyst size reduction, ideally to the sub 400 microns group. The number of patients in the non-responder group is too small to lend sufficient power to the study. Though this is beyond the scope of this study, it will be informative for the readers to know if any alternative treatment was provided to the non-responder group after 3 months and if they responded to that treatment. Going ahead, if the patients do not respond adequately (less than 10% macular edema reduction from baseline) following one or a maximum of two injections, they should be provided with the option of alternate treatments. Financial support and sponsorship: Nil. Conflicts of interest: There are no conflicts of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be) University, 8-Kalinga Nagar, Bhubaneswar, Odisha, India.
Zitieren
APA
Panigrahi, P. K., & Patro, M. (2024). Visual outcomes following anti-VEGF therapy in patients with DME. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_40_24
Vancouver
Panigrahi PK, Patro M. Visual outcomes following anti-VEGF therapy in patients with DME. Indian Journal of Ophthalmology. 2024. doi:10.4103/ijo.ijo_40_24
BibTeX
@article{Panigrahi2024,
author = {Panigrahi, Pradeep K and Patro, Manaswini},
title = {Visual outcomes following anti-VEGF therapy in patients with DME},
journal = {Indian Journal of Ophthalmology},
year = {2024},
doi = {10.4103/ijo.ijo_40_24}
}
EUVIMED